Abstract
Concentrations of 5-fluorouracil (FU) were measured in the plasma of patients receiving i.v. infusions of the drug for 5 days as treatment for adenocarcinoma of the gastrointestinal tract. Concentrations of FU varied widely in many patients. Concentration of drug X time of infusion (C X t values) were calculated. Patients showing a partial response or stabilization of disease had significantly higher C X t values than non-responders. Methyl CCNU did not affect the C X t values of FU. Determination of the plasma concentration of FU would allow the dose of the drug to be adjusted to maintain high concentrations of FU in the plasma. Our data suggest that such high concentrations would increase the response rate in this disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Hillcoat, B., McCulloch, P., Figueredo, A. et al. Clinical response and plasma levels of 5-fluorouracil in patients with colonic cancer treated by drug infusion. Br J Cancer 38, 719–724 (1978). https://doi.org/10.1038/bjc.1978.278
Issue Date:
DOI: https://doi.org/10.1038/bjc.1978.278
This article is cited by
-
High-dose chemotherapy for relapsed testicular germ cell tumours
Nature Reviews Urology (2023)
-
Feasibility of 5-fluorouracil pharmacokinetic monitoring using the My-5FU PCMâ„¢ system in a quaternary oncology centre
Cancer Chemotherapy and Pharmacology (2018)
-
Pharmacokinetically guided algorithm of 5-fluorouracil dosing, a reliable strategy of precision chemotherapy for solid tumors: a meta-analysis
Scientific Reports (2016)
-
Therapeutic drug monitoring of 5-fluorouracil
Cancer Chemotherapy and Pharmacology (2016)
-
'Toxgnostics': an unmet need in cancer medicine
Nature Reviews Cancer (2014)